| Literature DB >> 19959385 |
Pascal Vanelderen1, Tom Rouwette, Tamas Kozicz, Eric Roubos, Jan Van Zundert, Rene Heylen, Kris Vissers.
Abstract
Even in present day pain therapy, neuropathic pain remains a challenge for clinicians to treat and a challenge for researchers to investigate. Different animal models have been developed to mimic neuropathic pain. Neurotrophins such as nerve growth factor, brain-derived neurotrophic factor and neurotrophin 3 have been studied extensively in these models, yet few review articles concerning brain-derived neurotrophic factor have been published. This article reassesses the literature concerning brain-derived neurotrophic factor expression in the sciatic nerve chronic constriction injury model, the sciatic nerve transection model, the spinal nerve ligation model and the spinal nerve transection model and discusses differences in regulation of brain-derived neurotrophic factor between these models and their causality with neuropathic pain. Copyright 2009 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19959385 DOI： 10.1016/j.ejpain.2009.09.006
Source DB: PubMed Journal: Eur J Pain ISSN： 1090-3801 Impact factor: 3.931